.svg)
average weight loss with glp-1 agonists In Obesity GLP-1 Medications for Weight Loss:
Description
17,18 Despite some evidence of their benefit for adipocytes and lipids, their precise role in lipid balance needs further investigation
& Ma, G
Bloating and Abdominal Distension: Individuals with gastroparesis frequently describe a sensation of bloating or a distended abdomen, creating discomfort and unease
In SURMOUNT-1 with non-diabetic participants, the 15mg dose produced that 20.9% figure mentioned above
Clinical trials have substantiated the efficacy of these agents in fostering weight loss, bringing a ray of hope for individuals grappling with obesity
